Recent Updates
Recently added Catalysts
IDYA

IDEAYA Biosciences Appoints Dr Karlene Cimprich, Ph D and Dr Kornelia Polyak, M D , Ph D to Scientific Advisory Board

Key Takeaway: IDEAYA Biosciences Appoints Dr Karlene Cimprich, Ph D and Dr Kornelia Polyak, M D , Ph D to Scientific Advisory Board
Price reaction · baseline $16.85 (2022-12-16 close) · clean, no other IDYA news in the window
day 0 close
-0.2%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma

Full Press Release Details

IDEAYA Biosciences Appoints Dr Karlene Cimprich, Ph D and Dr Kornelia Polyak, M D , Ph D to Scientific Advisory Board.
Last updated: Dec 19, 2022